RxDoctor Payments Data

Drazen Jukic, MD

Dermatopathology · Savannah, GANPI 1134193774

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $11,255 of the $16,066 with a category attached, or 70.1%. 7 manufacturers reported payments, led by Roche Diagnostics Corporation at 58.5% of the total. Among dermatopathology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,066in general payments, 2019–2025

Across 31 payments — averaging $518.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$9K
  • Ventana Medical Systems, Inc.$4K
  • Sanofi$2K
  • Dermavant Sciences, Inc.$39
  • Organon$35
  • E.r. Squibb & Sons, L.L.C.$16
  • plus $12 from 1 others

What the payments were for

  • Consulting fees$2,16813%
  • Speaking & faculty fees$11,25570%
  • Travel & lodging$1,5039%
  • Food & beverage$1,1417%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,066 in reported general payments places this provider in the 95th percentile of 25 dermatopathology providers in Georgia.

See all dermatopathology providers in Georgia

Medicare billing

Part B allowed, 2024
$775,773
Medicare patients
3,624
Services billed
9,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatopathology in Savannah

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →